Biovet, the animal health vaccine producing company, will make an investment to the tune of Rs 200 crore.
The investment is part of its expansion plans to meet the growing market demands, especially to tackle Foot & Mouth Disease (FMD) and Brucellosis in animals.
The company has commenced work towards expanding the FMD vaccine manufacturing facility in Malur, Karnataka.
The company will construct a new Brucella Vaccine Production facility to produce 100 million doses. The expansion of the FMD vaccine facilities will help deliver 200 million doses.
With this, the company will be the world’s largest manufacturer of this vaccine.
The project will provide job opportunities in construction phase.